Decreased baroreflex sensitivity in Parkinson’s disease is associated with orthostatic hypotension
Objective: To compare the baroreflex sensitivity (BRS) of Parkinson’s disease patients with those of an age-matched control population, and to determine BRS association with blood pressure,…Heart Rate Variability and Cognitive Impairment in Parkinson’s Disease
Objective: To evaluate the association between the heart rate variability (HRV) and cognitive impairment in PD patients. Background: Emerging evidence suggests an association between cognitive…Prevalence of orthostatic hypotension and postprandial hypotension in neurodegenerative diseases with synucleinopathy: a systematic review and meta-analysis
Objective: This study aimed to evaluate the prevalence of orthostatic hypotension (OH) and postprandial hypotension (PPH) in patients with Parkinson's disease (PD), multiple system atrophy…Instrumental evaluation of sleep disturbance and autonomic nervous system dysfunction in idiopathic Parkinson’s disease
Objective: The aim of the study was the instrumental evaluation of occurrence and intensity of autonomic and sleep disturbances in patients with idiopathic PD. Background:…Droxidopa and Midodrine Treatment Persistence in Patients with Orthostatic Hypotension
Objective: To determine the treatment persistence of droxidopa and midodrine in patients with orthostatic hypotension (OH) or neurogenic orthostatic hypotension (nOH) when medication cost was…Effects of orthostatic hypotension and supine hypertension on cognition in Parkinson’s disease
Objective: The purpose of this study was to investigate the correlation of hemodynamic parameters and cognition in patients with PD. Background: Cognitive impairment is common…Preclinical cardiovascular sympathoexcitatory effects of TD-9855, a novel norepinephrine transporter (NET) inhibitor in development for the treatment of symptomatic neurogenic orthostatic hypotension (nOH) in patients with primary autonomic failure
Objective: TD-9855 is a novel NET inhibitor (1) being studied for the treatment of symptomatic nOH. The objective of the present study was to characterize…Levodopa Induced Orthostatic Hypotension in Parkinson’s Disease: A Single-Dose Response Study
Objective: To determine the effect and risk factors of a single dose levodopa induced OH in PD Background: Levodopa (LD) is widely recognised as the…Assessment of Autonomic Dysfunction in Parkinson’s Disease
Objective: Assessment of autonomic dysfunction in patients with Parkinson's disease and further comparison with patients without autonomic symptoms Background: A frequent disabling complication of Parkinson’s…Burden of autonomic neuropathy in Parkinson’s disease patients treated with advanced therapies
Objective: To analyze the prevalence and the functional burden of autonomic neuropathy (AN) in advanced Parkinson’s disease (PD) patients who underwent subthalamic deep brain stimulation…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- Next Page »